Condition
Respiratory Syncytial Virus Bronchiolitis
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02618213Not ApplicableCompletedPrimary
Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.
NCT02911935Phase 2CompletedPrimary
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
NCT01140048CompletedPrimary
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
Showing all 3 trials